CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 282 enrolled
Drug / intervention
CyPass Micro-Stent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02700984
NCT02700984N/ACompleted
CompareCT.gov

An Observational Multicenter Clinical Study to Assess the Long-Term Safety of the CyPass Micro-Stent in Patients With Primary Open Angle Glaucoma Who Have Completed Participation in the COMPASS Trial

Alcon Research·interventional·Posted Mar 7, 2016·Updated Jan 24, 2024

In Brief

A clinical study evaluating CyPass Micro-Stent and Cataract Surgery for Primary Open Angle Glaucoma (POAG). Completed, enrolled 282 participants across 22 sites.

Detailed Summary

The purpose of this study is to evaluate the long-term safety of the CyPass Micro-Stent in subjects who completed Study Protocol TMI-09-01, COMPASS Trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Open Angle Glaucoma (POAG)
CountriesUnited States
CollaboratorsTranscend Medical, Inc.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 7, 2016
Enrollment StartMar 30, 2016
Primary CompletionApr 18, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 10.3 years ago

Interventions

CyPass Micro-Stentdevice

The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front into the back of the eye. The device is implanted after completion of cataract surgery.

Cataract Surgeryprocedure

Cataract surgery involves the removal of the natural lens, which has become clouded (called a cataract), and insertion of an artificial lens (called an intraocular lens). This procedure is done through a small surgical incision in the eye.